Myopathies in critical illness: Characterization and nutritional aspects

Journal of Nutrition

Volumn 135, Issue 7, 2005, Pages

  Burnham, Ellen L ^a   Moss, Marc ^a   Ziegler, Thomas R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol abuse; Arginine; Glutamine; Glutathione; Neuromuscular diseases

Indexed keywords

AMINO ACID; DNA; GLUTAMINE; GLUTATHIONE; PROTEIN;

ALCOHOL ABUSE; AMINO ACID METABOLISM; CLINICAL FEATURE; CONFERENCE PAPER; CRITICAL ILLNESS; ELECTROMYOGRAM; HUMAN; INTENSIVE CARE; MUSCLE METABOLISM; MYOPATHY; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PROTEIN DEGRADATION;

EID: 22144472601     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.7.1818s     Document Type: Conference Paper

References (42)

1. Biolo, G., Grimble, G., Preiser, J.-C., Leverve, X., Jolliet, P., Planas, M., Roth, E., Wernerman, J. & Pichard, C. (2002) Position paper of the ESCIM Working Group on Nutrition and Metabolism. Metabolic basis of nutrition in intensive care unit patients: ten critical questions. Int. Care Med. 28: 1512-1520.
2. Van den Berghe, G. (2000) Novel insights into the neuroendocrinology of critical illness. Eur. J. Endocrinol. 143: 1-13.
3. Pingleton, S. K. (2001) Nutrition in chronic critical illness. Clin. Chest Med. 22: 149-163.
4. Hill, A. G. (2000) Initiators and propagators of the metabolic response to injury. World J. Surg. 24: 624-629.
5. DeJonghe, B., Sharshar, T., Lefaucheur, J.-P., Authier, F.-J., Durand-Zeleski, I., Boussarsar, M., Cerf, C., Renaud, E., Mersati, F., Carlet, J., Raphael, J. C. & Outin, H. (2002) Paresis acquired in the intensive care unit: A prospective multicenter study. J. Am. Med. Assoc. 22: 2859-2867.
6. Coakley, J. H., Nagendran, K., Honavar, M. & Hinds, C. J. (1993) Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Int. Care Med. 19: 323-328.
7. Lacomis, D., Petrella, J. T. & Giuliani, M. J. (1998) Causes of neuromuscular weakness in the intensive care unit: a study of 92 patients. Muscle Nerve 21: 610-617.
8. Gamrin, L., Essen, P., Forsberg, A. M., Hultman, E. & Wernerman, J. (1996) A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit. Care Med. 24: 575-583.
9. Gamrin, L., Andersson, K., Hultman, E., Nilsson, E., Essen, P. & Wernerman, J. (1997) Longitudinal changes of biochemical parameters in muscle during critical illness. Metabolism 46: 756-762.
10. Jackson, N. C., Carroll, P. V., Russell-Jones, D. L., Sonksen, P. H., Treacher, D. F. & Umpleby, A. M. (1999) The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism. Am. J. Physiol. Endocrinol. Metab. 276: E163-E170.
11. Mitch, W. E. & Goldberg, A. L. (1996) Mechanisms of muscle wasting: the role of the ubiquitin-proteosome pathway. N. Engl. J. Med. 335: 1897-1905.
12. Wagenmakers, A.J.M. (2000) Muscle function in critically ill patients. Clin. Nutr. 20: 451-454.
13. Hund, E. (1999) Myopathy in critically ill patients. Crit. Care Med. 27: 2544-2547.
14. Zochodne, D. W., Ramsay, D. A., Saly, V., Shelley, S, & Moffatt, S. (1994) Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 17: 285-292.
15. Latronico, N., Fenzi, F., Recupero, D., Guarneri, B., Tomelleri, G., Tonin, P., DeMaria, G., Antonini, L., Rizzuto, N. & Candiani, A. (1996) Critical illness myopathy and neuropathy. Lancet 347: 1579-1582.
16. Hund, E. (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J. Neurol. 248: 929-934.
17. Lacomis, D., Zochodne, D. W. & Bird, S. J. (2000) Critical illness myopathy. Muscle Nerve 23: 1785-1788.
18. Ferrando, A. A. (2000) Effects of inactivity and hormonal mediators on skeletal muscle during recovery from trauma. Curr. Opin. Clin. Nutr. Met. Care 3: 171-175.
19. Novak, F., Heyland, D. K., Avenell, A., Drover, J. W. & Su, X. (2002) Glutamine supplementation in serious illness: a systematic review of the evidence. Crit. Care Med. 30: 2022-2029.
20. Griffiths, R. D., Allen, K. D., Andrews, F. J. & Jones, C. (2002) Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition 18: 546-552.
21. Garcia de Lorenzo, A., Ortiz-Leyba, C., Planas, M., Montejo, J. C., Nunez, R., Ordonez, F. J., Aragon, C. & Jiminez, F. J. (1997) Parenteral administration of different amounts of branch-chain amino acids in septic patients: clinical and metabolic aspects. Crit. Care Med. 25: 418-424.
22. Heyland, D. K., Dhaliwal, R., Drover, J. W., Gramlich, L. & Dodek, P. (2003) Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. J. Parenter. Enteral Nutr. 27: 355-373.
23. Berard, M., Zazzo, J. & Condat, P. (2000) Total parenteral nutrition enriched with arginine and glutamate generates and limits protein catabolism in surgical patients hospitalized in intensive care units. Crit. Care Med. 28: 3637.
24. Jonas, C. R., Puckett, A. B., Jones, D. P., Griffith, D. P., Szeszycki, E. E., Bergman, G. F., Furr, C. E., Tyre, C., Carlson, J. L., Galloway, J. R., Blumberg, J. B. & Ziegler, T. R. (2000) Plasma antioxidant status after high-dose chemotherapy: A randomized trial of parenteral nutrition in bone marrow transplant patients. Am. J. Clin. Nutr. 72: 181-189.
25. Yu, Y. M., Ryan, C. M., Fei, Z. W. & Lu, X. M. (2002) Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am. J. Physiol. 282: E247.
26. Hammarqvist, F., Luo, J.-L., Cotgreave, I. A., Andersson, K. & Wernerman, J. (1997) Skeletal muscle glutathione is depleted in critically ill patients. Crit. Care Med. 25: 78-84.
27. Ortolani, O., Conti, A. & De Gaudio, A. R. (2000) The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am. J. Respir. Crit. Care Med. 161: 1907.
28. Chang, D. W., DeSanti, L. & Demling, R. H. (1998) Anticatabolic and anabolic strategies in critical illness: A review of current treatment modalities. Shock 10: 155-160.
29. Ross, R., Miell, J., Freeman, E., Jones, J., Matthews, D., Preece, M. & Buchanan, C. (1991) Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clin. Endocrinol. 35: 47-54.
30. Ziegler, T. R., Young, L. S., Ferrari-Baliviera, E., Demling, R. H. & Wilmore, D. W. (1990) Use of human growth hormone combined with nutritional support in a critical care unit. J. Parenter. Enter. Nutr. 14: 574-581.
31. Voerman, H. J., Strack van Schijndel, R.J.M. & Goeneveld, A.B.J. (1992) Effect of recombinant human growth hormone in patients with severe sepsis. Ann. Surg. 216: 648-655.
32. Richard, C., Kyle, U., Chevrolet, J. C., Jolliet, P., Slosman, D., Mensi, N., Temler, E. & Ricou, B. (1996) Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study. Crit. Care Med. 24: 403-13.
33. Yarwood, G. D., Ross, R. J., Medbak, S., Coakley, J. & Hinds, C. J. (1997) Administration of human recombinant insulin-like growth factor-1 in critically ill patients. Crit. Care Med. 25: 1352-1361.
34. Herndon, D. N., Ramzy, P. I., DebRoy, M. A., Zheng, M., Ferrando, A. A., Chinkes, D. L., Barret, J. P., Wolfe, R. R., & Wolf, S. E. (1999) Muscle protein catabolism after severe burn: Effects of IGF-I/IGFBP-3 treatment. Ann. Surg. 229: 713-722.
35. Kimbrough, T., Shernan, S., Ziegler, T. R., Scheltinga, M. & Wilmore, D. W. (1991) Insulin-like growth factor I (IGF-I) response is comparable following intravenous and subcutaneous administration of growth hormone. J. Surg. Res. 51: 472-476.
36. Dahn, M. S. & Lange, M. P. (1998) Systemic and splanchnic metabolic response to exogenous human growth hormone. Surgery 123: 528-538.
37. Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinck, X. G. & Hinds, C. J. (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med. 341: 785-792.
38. Van den Berghe, G., Wouters, P., Weekers, F., et al. (2001) Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345: 1359-1367.
39. Ekbom, K., Hed, R., Kirstein, L. & Astrom, K.-E. (1964) Muscular affectations in chronic alcoholism. Arch. Neurol. 10: 449-460.
40. Preedy, V. R., Peters, T. J., Patel, V. B. & Miell, J. P. (1994) Chronic alcoholic myopathy: transcription and translational alterations. FASEB J. 8: 1146-1151.
41. Estruch, R., Nicolas, J. M., Villegas, E., Junque, A. & Urbano-Marquez, A. (1993) Relationship between ethanol-related diseases and nutritional status in chronically alcoholic men. Alcohol Alcohol. 28: 543-550.
42. Duane, P. & Peters, T. J. (1988) Nutritional status in alcoholics with and without chronic skeletal muscle myopathy. Alcohol Alcohol. 23: 271-277.